Cartesian Therapeutics, Inc. · NASDAQ:RNAC
Timothy A. Springer reported a 36.90% stake in Cartesian Therapeutics, Inc. (Schedule 13D/A)
Event Jan 13, 2025 · Filed Jan 15, 2025
Timothy A. Springer reported a 36.90% stake in Cartesian Therapeutics, Inc., 9,555,394 shares, with active intent on Jan 13, 2025. Filed Jan 15, 2025 (Schedule 13D/A).
- Stake
- 36.90%
- Shares
- 9,555,394
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Timothy A. Springer | 36.90% | 9,555,394 |
| TAS Partners LLC | 2.20% | 563,206 |
| Chafen Lu | 1.40% | 350,740 |
Source
Related
- Cartesian Therapeutics, Inc.
- Timothy A. Springer
- Cartesian Therapeutics, Inc. shareholders
- Schedule 13D/A · Timothy A. Springer · Dec 23, 2024
- Schedule 13G · Barclays PLC · Aug 13, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Jul 22, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Form 4 · Hoge Elizabeth · Apr 6, 2026
- Form 4 · Kalayoglu Murat · Apr 6, 2026